217 related articles for article (PubMed ID: 15675025)
1. Project Bioshield: protecting Americans from terrorism.
Meadows M
FDA Consum; 2004; 38(6):32-3. PubMed ID: 15675025
[No Abstract] [Full Text] [Related]
2. Booming biosafety labs probed.
Wadman M
Nature; 2009 Oct; 461(7264):577. PubMed ID: 19794463
[No Abstract] [Full Text] [Related]
3. Bioterrorism: a clear and present danger.
Lane HC; Montagne JL; Fauci AS
Nat Med; 2001 Dec; 7(12):1271-3. PubMed ID: 11726956
[No Abstract] [Full Text] [Related]
4. Containing risk.
Nature; 2009 Oct; 461(7264):569-70. PubMed ID: 19794448
[No Abstract] [Full Text] [Related]
5. Ethics and bioterrorism research.
Bull Med Ethics; 2004 May; (198):13-20. PubMed ID: 15832477
[No Abstract] [Full Text] [Related]
6. Our first line of defense against bioterrorism part 2.
Simpson RL
Nurs Manage; 2002 May; 33(5):10, 11. PubMed ID: 12006878
[TBL] [Abstract][Full Text] [Related]
7. CDC: be alert to symptoms associated with bioterrorism.
Levenson D
Rep Med Guidel Outcomes Res; 2001 Nov; 12(21):1-2, 5. PubMed ID: 12382635
[No Abstract] [Full Text] [Related]
8. Biodefence on the research agenda.
Fauci AS
Nature; 2003 Feb; 421(6925):787. PubMed ID: 12594484
[No Abstract] [Full Text] [Related]
9. A dose of reality for the health watchdogs.
Kluger J
Time; 2001 Oct; 158(19):65-6. PubMed ID: 11699134
[No Abstract] [Full Text] [Related]
10. US restrictions limit anthrax networking.
Ozin A; Bade K; Kaufmann SH
Nature; 2004 Oct; 431(7011):897. PubMed ID: 15496891
[No Abstract] [Full Text] [Related]
11. Responding to anthrax.
Borg MA; Tieck WC
J Dent Technol; 2001; 18(8):12-4, 28. PubMed ID: 11885187
[No Abstract] [Full Text] [Related]
12. Bioterrorism watch. Building a bridge over the abyss: will bioterrorism help bring disjointed health system together?
Evans G
Hosp Peer Rev; 2002 Apr; 27(4):suppl 1-2. PubMed ID: 11951727
[No Abstract] [Full Text] [Related]
13. Lessons learned from the CDC's post-exposure prophylaxis program following the anthrax attacks of 2001.
Bresnitz EA
Pharmacoepidemiol Drug Saf; 2005 Jun; 14(6):389-91. PubMed ID: 15924332
[No Abstract] [Full Text] [Related]
14. Anthrax bioterrorism: lessons learned and future directions.
Hughes JM; Gerberding JL
Emerg Infect Dis; 2002 Oct; 8(10):1013-4. PubMed ID: 12396907
[No Abstract] [Full Text] [Related]
15. Expanding Bioshield: a call for caution.
May T
Am J Public Health; 2007 Apr; 97 Suppl 1(Suppl 1):S23-5. PubMed ID: 17413075
[TBL] [Abstract][Full Text] [Related]
16. Crackdown on hazardous agents raises concern for bona fide labs.
Knight J
Nature; 2001 Nov; 414(6859):3-4. PubMed ID: 11689899
[No Abstract] [Full Text] [Related]
17. Bioterrorism today.
Snell N
Biologist (London); 2002 Jun; 49(3):140. PubMed ID: 12097718
[TBL] [Abstract][Full Text] [Related]
18. Bioterrorism.
Runyon C
NCSL Legisbrief; 2001; 9(21):1-2. PubMed ID: 11850891
[No Abstract] [Full Text] [Related]
19. Bioterrorism watch. Anthrax aftermath: adverse drug reactions, vaccine controversy undercut CDC extended treatment offer.
Evans G
Hosp Peer Rev; 2002 Mar; 27(3):suppl 1-4. PubMed ID: 11905387
[No Abstract] [Full Text] [Related]
20. Bioterrorism. Facing a security deadline, labs get a 'provisional' pass.
Enserink M
Science; 2003 Nov; 302(5647):962-3. PubMed ID: 14605333
[No Abstract] [Full Text] [Related]
[Next] [New Search]
